4th Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$2,330,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Research and experimentation tax incentives and international tax issues, including: Administration's FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means Discussion Draft

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
NANCY ELLEN MCCARTHY —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Executive Office of the President (EOP)

Copyright/Patent/Trademark CPT

H.R. 3309, The Innovation Act of 2013 (heightened pleading standards, discovery stay) S. 1720, The Patent Transparency and Improvements Act (demand letters, customer stay) S. 1013, The Patent Abuse Reduction Act (heightened pleading standards, discovery stay) S. 1612, The Patent Litigation Integrity Act (bonding)Trans-Pacific Partnership (12 years data exclusivity) S. 866, The Patent Quality Improvement Act (covered business method patents)

LobbyistCovered position, as disclosed
WILLIAM O'BRIEN —
HELEN RHEE —

Contacted: U.S. Trade Representative (USTR); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1612 (113th), S. 1013 (113th), S. 866 (113th), H.R. 3309 (113th), S. 1720 (113th)

Health Issues HCR

H.R. 3204, The Drug Quality and Security Act (Track and Trace) S. 3187, The Food and Drug Safety and Innovation Act (User Fee Sequester) Biosimilars, no specific bill

LobbyistCovered position, as disclosed
WILLIAM O'BRIEN —
HELEN RHEE —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Executive Office of the President (EOP); SENATE

Bills named: S. 3187 (113th), H.R. 3204 (113th)

Medicare/Medicaid MMM

End Stage Renal Disease and issues related to dialysis Medicare Part B drug reimbursement issues (Average Sales Price) S. 1817, SGR Repeal and Medicare Beneficiary Access Act of 2013 (Medicare Physician Payments) H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013H.J. Res. 59, Continuing Appropriations 2014 (Medicare Part B, Medicare Physician Payments)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
CHAKA BURGESS —
L NICOLE CURRIE —
JESSE KERNS —
REBECCA MANDELL —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); U.S. Trade Representative (USTR)

Bills named: H.R. 2810 (113th), S. 1817 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.